Bradley J. Bolzon Ph.D., Director, 10% Owner at Black Diamond Therapeutics, Inc. (BDTX), sold 131,460 shares at $33.26 ($3.1M) on 2020-10-06, disclosed to the SEC on 2020-10-08.
Open-market sale of $3.1M BDTX by Director, 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $33.26 | 2,110 | $70K | 2.3% |
| 2 | $33.26 | 2,110 | $70K | 2.3% |
| 3 | $33.26 | 15,980 | $531K | 17.3% |
| 4 | $33.26 | 15,980 | $531K | 17.3% |
| 5 | $0.00 | 39,608 | $0 | 0.0% |
| 6 | $33.56 | 3,246 |
| $109K |
| 3.5% |
| 7 | $33.56 | 3,246 | $109K | 3.5% |
| 8 | $33.56 | 24,590 | $825K | 26.9% |
| 9 | $33.56 | 24,590 | $825K | 26.9% |
| Total | $23.37 avg | 131,460 | $3.1M | 100% |
| Filing → |
| CRSP | SELL | 2021-06-30 | $14.1M | — | Filing → |
| CRSP | SELL | 2021-06-30 | $9.2M | — | Filing → |
| CRSP | SELL | 2021-06-15 | $2.3M | — | Filing → |